Shopping Cart 0
Cart Subtotal
USD 0

OncoSec Medical Inc (ONCS) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body's immune system and attack cancer. It's lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. OncoSec is conducting pipeline programs for various indications which include metastatic melanoma, triple negative breast cancer and solid tumors. It is also identifying and developing novel immune-targeting agents for use with the ImmunoPulse platform. The company conducts pre-clinical and clinical studies targeting various cancers in collaboration with various academic medical centers and companies. OncoSec is headquartered in San Diego, California, the US.

OncoSec Medical Inc (ONCS)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

OncoSec Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

OncoSec Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

OncoSec Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

OncoSec Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

OncoSec Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

OncoSec Medical Inc, Medical Equipment, Deal Details 11

Partnerships 11

OncoSec Medical Enters into Agreement with Jounce Therapeutics 11

OncoSec Medical Enters into Agreement with Inhibrx 12

OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 13

Equity Offering 14

OncoSec Medical Raises USD8 Million in First Tranche of Private Placement of Shares 14

OncoSec Medical Raises USD23 Million in Public Offering of Shares 15

OncoSec Medical Plans to Raise up to USD16 Million in Public Offering of Shares 16

OncoSec Medical to Raise USD9.3 Million in Private Placement of Shares upon Exercise of Warrants 17

OncoSec Medical Raises USD7 Million in Private Placement of Shares 18

Oncosec Medical Raises USD5 Million in Private Placement of Shares upon Exercise of Warrants 20

OncoSec Medical Plans to Raise up to USD8.4 Million in Public Offering of Shares 21

OncoSec Medical Raises USD10 Million in Registered Direct Offering 22

OncoSec Medical Raises USD13.6 Million in Private Placement of Shares 23

OncoSec Medical Raises USD16 Million in Private Placement of Shares and Warrants 24

OncoSec Medical Completes Private Placement Of Shares For USD 12 Million 25

OncoSec Medical Completes Private Placement Of Common Stock For USD 7 Million 26

OncoSec Medical Completes Public Offering Of Units For USD 8 Million 27

OncoSec Medical Inc-Key Competitors 29

OncoSec Medical Inc-Key Employees 30

OncoSec Medical Inc-Locations And Subsidiaries 31

Head Office 31

Other Locations & Subsidiaries 31

Recent Developments 32

Financial Announcements 32

Jun 01, 2017: OncoSec Announces Third Quarter and YTD Results for Fiscal Year 2017 32

Mar 16, 2017: OncoSec Announces Second Quarter and YTD Results for Fiscal Year 2017 34

Corporate Communications 35

Jul 30, 2018: OncoSec Appoints Robert W. Ashworth, Ph.D. as Vice President, Regulatory 35

Jul 16, 2018: OncoSec names Sara M. Bonstein as chief financial officer and chief operating officer 36

Jan 16, 2018: OncoSec Appoints Veteran Biopharma Executive Gregory T. Mayes To Board Of Directors 37

Dec 05, 2017: OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to CSO 38

Nov 07, 2017: OncoSec Appoints Daniel J. O'Connor as Chief Executive Officer to Lead Next Stage of Growth as a Fully Integrated Late Stage Development and Commercial Company 39

Sep 07, 2017: OncoSec Appoints Industry Leader Daniel J. O'Connor to its Board of Directors 40

Sep 05, 2017: OncoSec Appoints Industry Veteran Annalisa Jenkins MBBS, FRCP to Board of Directors 41

Legal and Regulatory 42

Jun 25, 2018: OncoSec added to the Russell Microcap Index 42

Product News 43

Nov 28, 2017: OncoSec Expands Intellectual Property Estate, Announces Issuance of Patents for ImmunoPulse Platform 43

May 02, 2017: OncoSec to Present at Biomarkers & Immuno-Oncology World Congress 2017 44

Other Significant Developments 45

Jun 28, 2018: OncoSec provides outlook for second half of 2018 45

Appendix 48

Methodology 48

About GlobalData 48

Contact Us 48

Disclaimer 48


List Of Figure

List of Figures

OncoSec Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

OncoSec Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

OncoSec Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

OncoSec Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

OncoSec Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

OncoSec Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

OncoSec Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

OncoSec Medical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

OncoSec Medical Inc, Medical Equipment, Key Facts, 2017 2

OncoSec Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

OncoSec Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

OncoSec Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

OncoSec Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

OncoSec Medical Inc, Deals By Market, 2012 to YTD 2018 9

OncoSec Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

OncoSec Medical Enters into Agreement with Jounce Therapeutics 11

OncoSec Medical Enters into Agreement with Inhibrx 12

OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 13

OncoSec Medical Raises USD8 Million in First Tranche of Private Placement of Shares 14

OncoSec Medical Raises USD23 Million in Public Offering of Shares 15

OncoSec Medical Plans to Raise up to USD16 Million in Public Offering of Shares 16

OncoSec Medical to Raise USD9.3 Million in Private Placement of Shares upon Exercise of Warrants 17

OncoSec Medical Raises USD7 Million in Private Placement of Shares 18

Oncosec Medical Raises USD5 Million in Private Placement of Shares upon Exercise of Warrants 20

OncoSec Medical Plans to Raise up to USD8.4 Million in Public Offering of Shares 21

OncoSec Medical Raises USD10 Million in Registered Direct Offering 22

OncoSec Medical Raises USD13.6 Million in Private Placement of Shares 23

OncoSec Medical Raises USD16 Million in Private Placement of Shares and Warrants 24

OncoSec Medical Completes Private Placement Of Shares For USD 12 Million 25

OncoSec Medical Completes Private Placement Of Common Stock For USD 7 Million 26

OncoSec Medical Completes Public Offering Of Units For USD 8 Million 27

OncoSec Medical Inc, Key Competitors 29

OncoSec Medical Inc, Key Employees 30

OncoSec Medical Inc, Other Locations 31

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

OncoSec Medical Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body's immune system and attack cancer. It's lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. OncoSec is conducting pipeline programs for various indications which include metastatic melanoma, triple negative breast cancer and solid tumors. It is also identifying and developing novel immune-targeting agents for use with the ImmunoPulse platform. The company conducts pre-clinical and clinical studies targeting various cancers in collaboration with various academic medical centers and companies. OncoSec is headquartered in San Diego, California, the US.

OncoSec Medical Inc (ONCS)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

OncoSec Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

OncoSec Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

OncoSec Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

OncoSec Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

OncoSec Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

OncoSec Medical Inc, Medical Equipment, Deal Details 11

Partnerships 11

OncoSec Medical Enters into Agreement with Jounce Therapeutics 11

OncoSec Medical Enters into Agreement with Inhibrx 12

OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 13

Equity Offering 14

OncoSec Medical Raises USD8 Million in First Tranche of Private Placement of Shares 14

OncoSec Medical Raises USD23 Million in Public Offering of Shares 15

OncoSec Medical Plans to Raise up to USD16 Million in Public Offering of Shares 16

OncoSec Medical to Raise USD9.3 Million in Private Placement of Shares upon Exercise of Warrants 17

OncoSec Medical Raises USD7 Million in Private Placement of Shares 18

Oncosec Medical Raises USD5 Million in Private Placement of Shares upon Exercise of Warrants 20

OncoSec Medical Plans to Raise up to USD8.4 Million in Public Offering of Shares 21

OncoSec Medical Raises USD10 Million in Registered Direct Offering 22

OncoSec Medical Raises USD13.6 Million in Private Placement of Shares 23

OncoSec Medical Raises USD16 Million in Private Placement of Shares and Warrants 24

OncoSec Medical Completes Private Placement Of Shares For USD 12 Million 25

OncoSec Medical Completes Private Placement Of Common Stock For USD 7 Million 26

OncoSec Medical Completes Public Offering Of Units For USD 8 Million 27

OncoSec Medical Inc-Key Competitors 29

OncoSec Medical Inc-Key Employees 30

OncoSec Medical Inc-Locations And Subsidiaries 31

Head Office 31

Other Locations & Subsidiaries 31

Recent Developments 32

Financial Announcements 32

Jun 01, 2017: OncoSec Announces Third Quarter and YTD Results for Fiscal Year 2017 32

Mar 16, 2017: OncoSec Announces Second Quarter and YTD Results for Fiscal Year 2017 34

Corporate Communications 35

Jul 30, 2018: OncoSec Appoints Robert W. Ashworth, Ph.D. as Vice President, Regulatory 35

Jul 16, 2018: OncoSec names Sara M. Bonstein as chief financial officer and chief operating officer 36

Jan 16, 2018: OncoSec Appoints Veteran Biopharma Executive Gregory T. Mayes To Board Of Directors 37

Dec 05, 2017: OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to CSO 38

Nov 07, 2017: OncoSec Appoints Daniel J. O'Connor as Chief Executive Officer to Lead Next Stage of Growth as a Fully Integrated Late Stage Development and Commercial Company 39

Sep 07, 2017: OncoSec Appoints Industry Leader Daniel J. O'Connor to its Board of Directors 40

Sep 05, 2017: OncoSec Appoints Industry Veteran Annalisa Jenkins MBBS, FRCP to Board of Directors 41

Legal and Regulatory 42

Jun 25, 2018: OncoSec added to the Russell Microcap Index 42

Product News 43

Nov 28, 2017: OncoSec Expands Intellectual Property Estate, Announces Issuance of Patents for ImmunoPulse Platform 43

May 02, 2017: OncoSec to Present at Biomarkers & Immuno-Oncology World Congress 2017 44

Other Significant Developments 45

Jun 28, 2018: OncoSec provides outlook for second half of 2018 45

Appendix 48

Methodology 48

About GlobalData 48

Contact Us 48

Disclaimer 48


List Of Figure

List of Figures

OncoSec Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

OncoSec Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

OncoSec Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

OncoSec Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

OncoSec Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

OncoSec Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

OncoSec Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

OncoSec Medical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

OncoSec Medical Inc, Medical Equipment, Key Facts, 2017 2

OncoSec Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

OncoSec Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

OncoSec Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

OncoSec Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

OncoSec Medical Inc, Deals By Market, 2012 to YTD 2018 9

OncoSec Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

OncoSec Medical Enters into Agreement with Jounce Therapeutics 11

OncoSec Medical Enters into Agreement with Inhibrx 12

OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 13

OncoSec Medical Raises USD8 Million in First Tranche of Private Placement of Shares 14

OncoSec Medical Raises USD23 Million in Public Offering of Shares 15

OncoSec Medical Plans to Raise up to USD16 Million in Public Offering of Shares 16

OncoSec Medical to Raise USD9.3 Million in Private Placement of Shares upon Exercise of Warrants 17

OncoSec Medical Raises USD7 Million in Private Placement of Shares 18

Oncosec Medical Raises USD5 Million in Private Placement of Shares upon Exercise of Warrants 20

OncoSec Medical Plans to Raise up to USD8.4 Million in Public Offering of Shares 21

OncoSec Medical Raises USD10 Million in Registered Direct Offering 22

OncoSec Medical Raises USD13.6 Million in Private Placement of Shares 23

OncoSec Medical Raises USD16 Million in Private Placement of Shares and Warrants 24

OncoSec Medical Completes Private Placement Of Shares For USD 12 Million 25

OncoSec Medical Completes Private Placement Of Common Stock For USD 7 Million 26

OncoSec Medical Completes Public Offering Of Units For USD 8 Million 27

OncoSec Medical Inc, Key Competitors 29

OncoSec Medical Inc, Key Employees 30

OncoSec Medical Inc, Other Locations 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

OncoSec Medical Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.